BioNTech partnering with UK Government on personalized mRNA cancer immunotherapies
BioNTech SE has signed a memorandum of understanding (MoU) with the Government of the United…
BioNTech SE has signed a memorandum of understanding (MoU) with the Government of the United…
Cancer Research Horizons, the innovation engine at the core of the world’s largest private funder…
Actimed Therapeutics Ltd has completed its second and final £5 million ($6 million) tranche of…
Roquefort Therapeutics is a biotech company developing first-in-class drugs in the high value and high…
Researchers at the University of Bristol in the U.K. funded by the British Heart Foundation…
Though plants may hold the key to new, effective medicines, sourcing these compounds sustainably is…
This week, we have three guests. We have conversations with Antoine Espinet, CEO of MicrofluidX;…
Alchemab Therapeutics has been awarded a grant of £1.7 million ($2 million) from Innovate UK’s…
STORM Therapeutics Ltd., which is working on discovering and developing novel small molecule therapies targeting…
Canary Wharf Group (CWG) and Kadans Science Partner are submitting a detailed planning application for…
Tachmed is looking to transform access to healthcare through technology. The company’s CEO, Paul Christie,…
Researchers from the University of Birmingham in the U.K., who identified a novel mechanism for…